Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss

Two injections into the vocal cords is the treatment plan and all coding information is included at the web site. BD

PALO ALTO, Calif., Sept 21, 2008 /PRNewswire via COMTEX/ -- Coapt Systems Inc. today announced the launch of its Novielle Voice family of injectable fillers at the 112th annual meeting of the American Academy of Otolaryngology -- Head and Neck Surgery (AAO-HNS) in Chicago, IL, September 21-24, 2008. The U.S. Food and Drug Administration (FDA) cleared Novielle Voice Gel and Novielle Voice GelPlus earlier this year for restoration of voice loss. Novielle Voice is available in two formulations based on a proprietary, bioabsorbable Acrylomer(TM) Complex. Novielle Voice is injected into the vocal folds to repair defects that cause the voice to become faint and speaking to become difficult.